Whole-Body MRI Metrics Signal Myeloma Prognosis
Abnormal bone marrow volume detected through whole-body dixon MRI provides significant prognostic value for patients with newly diagnosed multiple myeloma, according to a study published in Magnetic Resonance Imaging. Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, highlighted the findings on X, noting that abnormal bone marrow volume correlates directly with progression-free survival and overall survival rates in this patient population.
Survival Rates Linked to Bone Marrow Volume
The research demonstrates clear statistical links between imaging results and patient outcomes. Progression-free survival yielded a hazard ratio of 1.88 with a 95% confidence interval spanning from 1.10 to 3.24 and a p-value of 0.022. Overall survival showed a hazard ratio of 2.71 with a 95% confidence interval between 1.31 and 5.58 and a p-value of 0.007. These metrics establish that expanded abnormal bone marrow volume serves as a reliable indicator of disease aggressiveness in newly diagnosed cases.
#Myeloma Paper of the Day: Abnormal bone marrow volume based on whole-body dixon MRI may be associated with with prognosis (PFS HR = 1.88, 95% CI = 1.10-3.24, p = 0.022; OS HR = 2.71, 95% CI = 1.31-5.58, p = 0.007) in newly diagnosed myeloma: https://t.co/nq9Wt0nRhc. #mmsm pic.twitter.com/CWT91c6nub
Research Team and Institutional Contributors
The study was conducted by a multi-institutional team of investigators. David F. Moreno, Ferran Nadeu, Marta Casado-Peláez, Caterina Mata, Ian Márquez-López, Marco A. Fernández, Sergi Vaqué, Elena Medina, Helena Llobregat, Marta Garrote, Joan Mañé, Oriol Cardús, Luis Gerardo Rodríguez-Lobato, Anna de Daniel, María Teresa Cibeira, Theo Gremen Oliveira, Elizaveta Kulaeva, Ester Lozano, Dolors Colomer, Laura Rosiñol, Ruben van Boxtel, Manel Esteller, and Carlos Fernández de Larrea contributed to the work. Their collaborative analysis evaluated the specific imaging patterns using dixon methodology to quantify bone marrow infiltration across skeletal sites.
Frequently Asked Questions About Myeloma MRI Findings
What is dixon MRI technology?
Dixon MRI is an advanced imaging technique that uses differences in the magnetic properties of fat and water to produce distinct images. In multiple myeloma research, this method allows clinicians to accurately measure abnormal bone marrow infiltration throughout the entire skeletal system.
How do the hazard ratios affect patient assessment?
The reported hazard ratios of 1.88 for progression-free survival and 2.71 for overall survival indicate a substantially higher risk of disease progression or mortality when abnormal bone marrow volume is detected on baseline scans.
Where was the complete study published?
The full research paper detailing these findings appears in the scientific journal Magnetic Resonance Imaging.
Worth a look